Completed
Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions
NCT03387540
- Conditions
- Cardiac Complication, Cardiomyopathies, Cardiovascular Diseases, +2 more
- Locations
-
- AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France